YZYunbin Zhang

Yunbin Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yunbin Zhang has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Feng Li

    Department of Tuberculosis, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China

    2 shared publications
  • Haicheng Tang

    Department of Respiratory and Critical Care Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China

    2 shared publications
  • Qingguo Wu

    Department of Respiratory and Critical Care Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China

    2 shared publications
  • Xiaolin Zhang

    Department of Respiratory and Critical Care Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China

    2 shared publications
  • Demi Hua

    Department of Tuberculosis, The Third People's Hospital of Tibet Autonomous Region, Lhasa 850000, China

    1 shared publication
  • Fanning Zeng

    Department of Anesthesiology, Nanfang Hospital, Southern Medical University

    1 shared publication

Latest Publications

  • Analysis of pathogens and risk factors of secondary pulmonary infection in patients with COVID-19

    by Haicheng Tang, Zhangyan Zhao, Xiaolin Zhang, Lei Pan, Qingguo Wu, Mei Wang, Yunbin Zhang, Feng Li


  • Open Access

    Differentiation independent neuroprotective role of Vcan + oligodendrocyte precursor cells in poststroke cognitive impairment recovery

    by Shanghang Shen, Yongjie Wang, Ruixue Xia, Fanning Zeng, Jun Cao, Xiaolei Liu, Yunbin Zhang, Zhanxiang Wang, Tao Tao

    The cell type-specific molecular pathology of post-stroke cognitive impairment (PSCI) in the hippocampus has not been thoroughly elucidated. We analyzed 27,069 cells by using single-cell RNA sequencing, and four oligodendrocyte precursor cell (OPC) subtypes were identified, Vcan + OPCs, which were determined to be the primary cluster among them. Additionally, we examined the features of endothelial cells (ECs) and found that Lcn2 + ECs might play neuroprotective roles via Vwf after stroke. These results may facilitate further studies attempting to identify new avenues of research and novel targets for PSCI treatment.


  • Integrated analyses reveal hsa_circ_0028883 as a diagnostic biomarker in active tuberculosis

    by Xiaolin Zhang, Qian Zhang, Qingguo Wu, Haicheng Tang, Linxiong Ye, Qilong Zhang, Demi Hua, Yunbin Zhang, Feng Li


  • Open Access

    Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy

    by Jun Shao, Yunbin Zhang, Guangming Fan, Yu Xin, Yong Yao

    Background: Diabetic retinopathy (DR) is the leading cause of blindness in the working age population. Transthyretin (TTR) showed a significantly decreased concentration in DR patients and exerted a visual protective effect by repressing neovascularization. This work intended to identify long non coding RNAs (lncRNAs) and explore their potential mechanism underlying the protective role of TTR.Methods: Transcriptome of human retinal endothelial cells (hRECs) treated with low glucose (LG), high glucose (HG) or high glucose with 4 μM TTR (HG + TTR) was conducted. Differentially expressed lncRNAs, mRNAs and TTR related lncRNAs and mRNA were acquired. Functional annotation and Gene Set Enrichment Analysis were applied to analyse TTR affected pathways and processes. Weighted gene co-expression network analysis (WGCNA) was implemented to obtain hub modules and genes. LncRNA-mRNA regulatory networks were constructed based oncis,transand competing endogenous RNAs acting mode. QRT-PCR was conducted to validate the expression of lncRNAs in aqueous humor and serum samples from 30 DR patients and 10 normal controls.Results: RNA-sequencing of hRECs treated with low glucose (LG), high glucose (HG) or high glucose with 4 μM TTR (HG + TTR) was conducted. 146,783 protein-coding transcripts, 12,403 known lncRNA transcripts and 1184 novel non-coding transcripts were characterized. A total of 11,407 differentially expressed mRNAs (DE-mRNAs), 679 differentially expressed lncRNAs (DE-lncRNAs) in HG group versus LG group, 6206 DE-mRNAs and 194 DE-lncRNAs in HG + TTR versus HG group were obtained, respectively. 853 TTR-mRNAs and 48 TTR-lncRNAs were acquired, and functionally involved in cell cycle, apoptosis, inflammation signalling pathway, response to oxidative stress, neovascularization and autophagy. The WGCNA analysis identified a hub module of 133 genes, with the core function of oxidative stress response, angiogenesis, MAPK pathway, cell proliferation and apoptosis. After qRT-PCR validation, a 3-lncRNA regulatory network was proposed. At last, lncRNAsMSTRG.15047.3andAC008403.3showed significantly relative higher expression levels in both aqueous humor and serum samples, compared with normal controls, andFRMD6-AS2was significantly down-regulated.Conclusions: TTR regulated mRNAs and biological processes including oxidative stress, inflammation signalling and autophagy. A 3-lncRNA regulatory network was characterized underlying TTR repressing neovascularization, and showed potential diagnostic performance in DR.